semaglutide ckd trial FLOWing with the — NephJC Effects of Semaglutide on CKD

Medicaid Services proposed to expand Medicare Part D and Medicaid to cover weight loss drugs

GLP-1 capsules are a better choice compared to GLP-1 powder and glp-1 drops

CMS GLP-1 Bridge Program: Medicare Part D coverage for weight-loss GLP-1 drugs starting July 1, 2026, including eligibility, covered medications, prior authorization, and copay rules.

Glucose spills into urine osmotic diuresis dehydration, electrolyte loss Clinical Features: Symptoms: Polyuria, polydipsia Nausea, vomiting Abdominal pain Fruity-smelling breath (due to ketones) Shortness of breath Confusion or drowsiness Signs: Dehydration (dry mucous membranes, sunken eyes) Kussmaul breathing (deep, labored breathing) Tachycardia, hypotension Altered mental status coma (in severe cases) Diagnostic Criteria (Blood tests): Parameter DKA Diagnostic Range Blood glucose